Schedule 13G ownership disclosure

Aardvark Therapeutics Inc

Common Stock, par value $0.00001 · CUSIP: 002942100

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Tien-Li Lee

    Shares: 2,983,724 · Class: 13.7%

  • Jane Wu Lee

    Shares: 2,983,724 · Class: 13.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-072801
Form type
SCHEDULE 13G
Filer
Aardvark Therapeutics, Inc.
CIK
CIK 1774857
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub